Adipose-derived mesenchymal stem cells accelerate diabetic wound healing in a similar fashion as bone marrow-derived cells.

We have previously shown that bone marrow-derived mesenchymal stem cells (BMSC) accelerate wound healing in a diabetic mouse model. In this study, we hypothesized that adipose tissue-derived stem cells (ADSC), cells of greater translational potential to human therapy, improve diabetic wound healing to a similar extent as BMSC. In vitro, the characterization and function of murine ADSC and BMSC as well as human diabetic and nondiabetic ADSC were evaluated by flow cytometry, cell viability, and VEGF expression. In vivo, biomimetic collagen scaffolds containing murine ADSC or BMSC were used to treat splinted full-thickness excisional back wounds on diabetic C57BL/6 mice, and human healthy and diabetic ADSC were used to treat back wounds on nude mice. Wound healing was evaluated by wound area, local VEGF-A expression, and count of CD31-positive cells. Delivery of murine ADSC or BMSC accelerated wound healing in diabetic mice to a similar extent, compared with acellular controls ( P < 0.0001). Histological analysis showed similarly increased cellular proliferation ( P < 0.0001), VEGF-A expression ( P = 0.0002), endothelial cell density ( P < 0.0001), numbers of macrophages ( P < 0.0001), and smooth muscle cells ( P < 0.0001) with ADSC and BMSC treatment, compared with controls. Cell survival and migration of ADSC and BMSC within the scaffolds were similar ( P = 0.781). Notch signaling was upregulated to a similar degree by both ADSC and BMSC. Diabetic and nondiabetic human ADSC expressed similar levels of VEGF-A ( P = 0.836) in vitro, as well as in scaffolds ( P = 1.000). Delivery of human diabetic and nondiabetic ADSC enhanced wound healing to a similar extent in a nude mouse wound model. Murine ADSC and BMSC delivered in a biomimetic-collagen scaffold are equivalent at enhancing diabetic wound healing. Human diabetic ADSC are not inferior to nondiabetic ADSC at accelerating wound healing in a nude mouse model. This data suggests that ADSC are a reasonable choice to evaluate for translational therapy in the treatment of human diabetic wounds.

[1]  Yue Wang,et al.  Human Adipose-Derived Stem Cells Promote Seawater-Immersed Wound Healing by Activating Skin Stem Cells via the EGFR/MEK/ERK Pathway , 2019, Stem cells international.

[2]  S. Stojanović,et al.  The Effect of Conditioned Media of Stem Cells Derived from Lipoma and Adipose Tissue on Macrophages’ Response and Wound Healing in Indirect Co-culture System In Vitro , 2019, International journal of molecular sciences.

[3]  A. Palmer,et al.  The Role of Macrophages in Acute and Chronic Wound Healing and Interventions to Promote Pro-wound Healing Phenotypes , 2018, Front. Physiol..

[4]  J. Guest,et al.  Diabetic foot ulcer management in clinical practice in the UK: costs and outcomes , 2018, International wound journal.

[5]  J. Black,et al.  The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system correlates with cost of care for diabetic foot ulcers treated in a multidisciplinary setting , 2017, Journal of vascular surgery.

[6]  J. Canner,et al.  The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system predicts wound healing but not major amputation in patients with diabetic foot ulcers treated in a multidisciplinary setting , 2017, Journal of vascular surgery.

[7]  Dalong Zhu,et al.  Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis† , 2017, Annals of medicine.

[8]  Wen Zhao,et al.  Functional hyaluronate collagen scaffolds induce NSCs differentiation into functional neurons in repairing the traumatic brain injury. , 2016, Acta biomaterialia.

[9]  B. Shu,et al.  Epidermal stem cells (ESCs) accelerate diabetic wound healing via the Notch signalling pathway , 2016, Bioscience reports.

[10]  F. Hyder,et al.  Delivery of mesenchymal stem cells in biomimetic engineered scaffolds promotes healing of diabetic ulcers. , 2016, Regenerative medicine.

[11]  M. Protasoni,et al.  Human adipose-derived stem cells promote vascularization of collagen-based scaffolds transplanted into nude mice , 2016, Regenerative medicine.

[12]  D. Agrawal,et al.  Mesenchymal stem cells and cutaneous wound healing: novel methods to increase cell delivery and therapeutic efficacy , 2016, Stem Cell Research & Therapy.

[13]  Atul Kumar,et al.  Collagen Promotes Higher Adhesion, Survival and Proliferation of Mesenchymal Stem Cells , 2015, PloS one.

[14]  Yanan Du,et al.  Biomaterials as carrier, barrier and reactor for cell-based regenerative medicine , 2015, Protein & Cell.

[15]  S. Patel,et al.  Adipose-Derived Stem Cells, their Secretome, and Wound Healing , 2014 .

[16]  C. Fromm-Dornieden,et al.  Adipose derived stem cells (ASC) in wound healing: Recent results in vitro and in vivo , 2013 .

[17]  Qingfeng Li,et al.  Adipose tissue‐derived stem cells (ADSCs) transplantation promotes regeneration of expanded skin using a tissue expansion model , 2013, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[18]  N. Kavantzas,et al.  Autologous Transplantation of Adipose-Derived Stem Cells Enhances Skin Graft Survival and Wound Healing in Diabetic Rats , 2013, Annals of plastic surgery.

[19]  G. Zambruno,et al.  Diabetes impairs adipose tissue–derived stem cell function and efficiency in promoting wound healing , 2013, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[20]  Qingfeng Li,et al.  Stem Cell Therapy for Lower Extremity Diabetic Ulcers: Where Do We Stand? , 2013, BioMed research international.

[21]  Thaned Kangsamaksin,et al.  Notch signaling in developmental and tumor angiogenesis. , 2011, Genes & cancer.

[22]  L. DiPietro,et al.  Factors Affecting Wound Healing , 2010, Journal of dental research.

[23]  Daping Yang,et al.  Local delivery of adipose-derived stem cells via acellular dermal matrix as a scaffold: a new promising strategy to accelerate wound healing. , 2009, Medical hypotheses.

[24]  Manuel A. González,et al.  Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis , 2009, Annals of the rheumatic diseases.

[25]  O. Myklebost,et al.  High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence , 2007, Journal of cellular and molecular medicine.

[26]  J. Gimble,et al.  Adipose-derived stem cells for regenerative medicine. , 2007, Circulation research.

[27]  Marjana Tomic-Canic,et al.  Cellular and molecular basis of wound healing in diabetes. , 2007, The Journal of clinical investigation.

[28]  G. Gurtner,et al.  Quantitative and reproducible murine model of excisional wound healing , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[29]  Min Zhu,et al.  Comparison of Multi-Lineage Cells from Human Adipose Tissue and Bone Marrow , 2003, Cells Tissues Organs.

[30]  Freddy Radtke,et al.  Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation , 2001, The EMBO journal.

[31]  H. Qian,et al.  Tissue-Specific Progenitor and Stem Cells Type 1 Diabetes Mellitus Donor Mesenchymal Stromal Cells Exhibit Comparable Potency to Healthy Controls In Vitro , 2016 .

[32]  F. Prósper,et al.  Adipose tissue-derived mesenchymal stem cells: isolation, expansion, and characterization. , 2013, Methods in molecular biology.

[33]  Tarynn M Witten,et al.  Impaired wound healing. , 2007, Clinics in dermatology.

[34]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.